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Background: Biomedical ontologies are representations of classes of entities in the biomedical domain and how
these classes are related in computer- and human-interpretable formats. Ontologies support data standardization
and exchange and provide a basis for computer-assisted automated reasoning. IDOBRU is an ontology in the
domain of Brucella and brucellosis. Brucella is a Gram-negative intracellular bacterium that causes brucellosis, the
most common zoonotic disease in the world. In this study, IDOBRU is used as a platform to model and analyze
how the hosts, especially host macrophages, interact with virulent Brucella strains or live attenuated Brucella
vaccine strains. Such a study allows us to better integrate and understand intricate Brucella pathogenesis and
host immunity mechanisms.
Results: Different levels of host-Brucella interactions based on different host cell types and Brucella strains were
first defined ontologically. Three important processes of virulent Brucella interacting with host macrophages were
represented: Brucella entry into macrophage, intracellular trafficking, and intracellular replication. Two Brucella
pathogenesis mechanisms were ontologically represented: Brucella Type IV secretion system that supports intracellular
trafficking and replication, and Brucella erythritol metabolism that participates in Brucella intracellular survival and
pathogenesis. The host cell death pathway is critical to the outcome of host-Brucella interactions. For better survival
and replication, virulent Brucella prevents macrophage cell death. However, live attenuated B. abortus vaccine strain
RB51 induces caspase-2-mediated proinflammatory cell death. Brucella-associated cell death processes are represented
in IDOBRU. The gene and protein information of 432 manually annotated Brucella virulence factors were represented
using the Ontology of Genes and Genomes (OGG) and Protein Ontology (PRO), respectively. Seven inference rules
were defined to capture the knowledge of host-Brucella interactions and implemented in IDOBRU. Current IDOBRU
includes 3611 ontology terms. SPARQL queries identified many results that are critical to the host-Brucella interactions.
For example, out of 269 protein virulence factors related to macrophage-Brucella interactions, 81 are critical to Brucella
intracellular replication inside macrophages. A SPARQL query also identified 11 biological processes important for
Brucella virulence.
Conclusions: To systematically represent and analyze fundamental host-pathogen interaction mechanisms, we
provided for the first time comprehensive ontological modeling of host-pathogen interactions using Brucella as
the pathogen model. The methods and ontology representations used in our study are generic and can be
broadened to study the interactions between hosts and other pathogens.* Correspondence: yongqunh@med.umich.edu
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In the field of infectious diseases, the study of the inter-
active relationships between pathogens and their hosts is
critically important. An infectious disease is the result of
intense interactions between a pathogen and its host. Dur-
ing these interactions both the host and the pathogen at-
tempt to manipulate each other using a complex network
mechanism to maximize their respective survival probabil-
ities. For the goal of survival and replication, the pathogen
may adapt different pathogenesis strategies to infect the
host. On the other hand, the host may apply innate and
adaptive immune defense mechanisms to fight against the
invading pathogen. Different live attenuated vaccines may
stimulate sufficient host immunity but does not induce
damaging effects on the host. For decades, scientists have
conducted research to study the different aspects of host-
pathogen interactions. In order to obtain a full picture of
the host-pathogen interaction mechanisms, separate data
from those studies needs to be integrated. Thus, a strategy
of knowledge representation, management and reasoning
based on the huge data resources is in need. Such a strat-
egy will enable the knowledge integration, complicated
biological data analysis, and provide insights for biologists
to generate new hypotheses.
Brucella is a Gram-negative, non-spore-forming, facul-
tative, intracellular bacterium that causes chronic zoonotic
brucellosis in humans and a variety of animal species [1].
Human brucellosis remains the most common zoonotic
disease worldwide, with more than 500,000 new human
cases reported annually [2]. A safe and effective human
vaccine is required but does not yet exist. A rational vac-
cine design would benefit from insightful understanding
of the interactions between host and Brucella, specifically,
Brucella pathogenesis and host defense mechanisms. Bru-
cella infections are typically chronic in nature [1], suggest-
ing a continuous interaction between host and Brucella.
To promote its long-term intracellular survival, Brucella
minimizes the activation of host inflammatory mecha-
nisms. For example, Brucella lipopolysaccharide (LPS) has
100- to 1000-fold decreased capability to activate pro-
inflammatory TNF-α and IL-1 cytokines compared to
similar concentrations of E. coli LPS [3]. Hundreds of Bru-
cella protein virulence factors participate in the Brucella
pathogenesis and interacting with host immune systems
[4, 5]. The immune systems in various Brucella hosts re-
spond poorly against virulent Brucella strains but very
well against live attenuated Brucella vaccine strains [6–8].
Such a complex host-pathogen interaction system involves
a number of cells, molecules and biological processes.
Therefore, the host-Brucella interactions present a good
example for an ontology-based exploration of complex
bacterial pathogenesis and host immunity mechanisms.
As an extension ontology of the Infectious Disease Ontol-
ogy (IDO) [9], Brucellosis Ontology (IDOBRU) is developedpreviously at our lab [10]. Following the good practice of
the OBO Foundry principles [11], IDOBRU was developed
under the framework of the Basic Formal Ontology (BFO)
[12] and IDO. BFO contains two branches, continuant and
occurrent [11, 13]. The continuant branch represents time-
independent entity such as material entity, and the occur-
rent branch represents time-related entity such as process.
By aligning different domain ontologies under the two
branches of BFO, the knowledge from broad biological
areas could be captured and organized under a compre-
hensive ontology-level structure. Since IDO aligns with
BFO, IDOBRU automatically aligns with BFO. IDOBRU
exemplifies IDO in the case of brucellosis, which covers a
broad range of topics, including host infection, zoonotic
disease transmission, symptoms, virulence factors, patho-
genesis, diagnosis, intentional release, vaccine prevention,
and treatment [10].
Since the study of host-Brucella interactions has been a
major brucellosis research effort, this paper goes beyond
the simplified introduction of virulence factors and patho-
genesis in the previous IDOBRU paper [10], and provides
more detailed ontological representation on various as-
pects of the host-pathogen interactions. In this report,
different types of the pathogen-side pathogenesis mecha-
nisms and host-side immune defense strategies are de-
scribed with specific examples. Comparing with the 245
virulence factors in the original IDOBRU ontology [10],
current version includes 432 virulence factors in Brucella.
Furthermore, a list of computer-understandable logic in-
ference rules is defined in this study to make the virulence
factors, host-Brucella interactions and related processes
computable. Use cases are provided to demonstrate how
such ontological representations and inference rule-based
automated reasoning help data integration and query in
the area of host-pathogen/vaccine interactions.
Results
In what follows, italics are used to make ontological ax-
ioms (i.e., statements that say what is true in the domain)
(http://www.w3.org/TR/owl2-syntax/), simple bold words
represent ontology relations, single quotes are used to rep-
resent ontology terms, and double quotes are used for text
definitions or emphases.
Overall design of ontological representing of
host-Brucella interaction
Various disciplines dissect interactions into different tai-
lored meanings. The definition of an interaction in the
host-pathogen interaction area includes a “two-way effect”
(i.e., host’s effect upon pathogen, and pathogen’s effect
upon host). The interactions between host (e.g., human)
and Brucella exemplifies a host-pathogen interaction in
the context of biology. As an intracellular bacterium, Bru-
cella strains are able to invade, survive and replicate for
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tured host cells. The GO term ‘interspecies interaction be-
tween organisms’ (GO_0044419) is defined as “any process
in which an organism has an effect on an organism of a
different species”. Without capturing the granularity at the
host cell level, this GO term is not sufficient for our case.
The definition of ‘host-Brucella interaction’ in IDOBRU is
“an interspecies interaction that is the physical encounter
of two parties: Brucella and its host organism or host cell.
While interacting, Brucella and its host organism or host
cell have effects upon each other.” The interaction in this
definition specifically emphasizes the physical encounter
and interaction of the two parties in an action. Also, given
that Brucella is an intracellular bacterium, it is important
to explicitly mention both of the host organism and the
host cell.
The host-Brucella interaction includes three main
parts: 1) ‘Brucella entry into host cell’ (IDO_0101170)
(the interaction at the interface between Brucella and
host), 2) ‘process of establishing Brucella infection in
host’ (IDO_0100426) (Brucella side response), and 3)
‘host anti-Brucella process’ (IDO_0100115) (host side
response). The IDOBRU term ‘Brucella entry into host
cell’ is a child term of GO ‘entry of bacterium into host
cell’ (GO_0035635). The IDOBRU term ‘process of es-
tablishing Brucella infection in host’ is a child term of
the IDO-core term ‘process of establishing an infection’
(IDO_0000603), which is under GO ‘biological process’.
The ‘host anti-Brucella process’ is a child term of GO
‘biological process’.
As we mentioned before, IDOBRU adopted Basic For-
mal Ontology version 2 (BFO 2) as its top level ontology
[10]. Favoring BFO is due to the integrative nature of
IDOBRU, a representation of all aspects of brucellosis, as
it requires integrating with other OBO library ontologies,
including the Cell Type Ontology (CL) [14], Chemical En-
tities of Biological Interest (ChEBI) [15], Gene Ontology
(GO) [16], Information Artifact Ontology (IAO) [17],
Ontology of Biomedical Investigations [18], Ontology of
General Medical Science (OGMS) (https://code.google.
com/p/ogms/), Ontology of Genes and Genomes (OGG)
[19], and Protein Ontology (PRO) [20]. BFO serves as a
common structure and a formal framework to seamlessly
integrate existing terms from all OBO foundry ontologies.
Under this consideration, we adopt relations formally de-
fined by the community as much as possible. To represent
the relations between molecular entities and its related
host-Brucella interactions, we adopted the relation has_
agent formally defined by Smith et al. [21]. In the defin-
ition provided by Smith et al., a p has_agent c at t denotes
a primitive relation between a process p, a continuant c
and a time t at which the continuant c is causally ac-
tive in the process [21]. The notion of “causally active”
is aimed to capture the “from-to” directionality natureof a biological process, which provides the explicit meas-
ure for the “two-way effect” interactions. Applying this re-
lation to model host-Brucella interaction, we differentiate
the host-Brucella interaction into two categories: 1) ‘Bru-
cella process towards host infection’, and 2) host anti-Bru-
cella process. The first category has Brucella as its agent,
and the second category has a host as its agent. In another
word, Brucella actively causes ‘establishing Brucella infec-
tion in host’, and host actively causes host anti-Brucella
processes. The Brucella and host both play an agent role in
the processes of host-Brucella interaction.
To go beyond the textual definitions and logically define
the ‘host-Brucella interaction’ and many other ontology
terms, two approaches were used. One approach was to
use an ontological axiom(s). An ontological axiom is a
statement that provides explicit logical assertions about
three types of things: classes, individuals and properties
(http://www.w3.org/TR/owl2-syntax/#Axioms). The other
facts implicitly contained in the ontology can be inferred
using a reasoning software program (i.e., a reasoner). An-
other approach is based on inference rules. On the Se-
mantic Web, the term “inference” means an automatic
procedure that can generate new relationship(s) based
on the data (e.g., ontology knowledge data) and some
additional information in the form of a vocabulary, for
example, a set of rules (http://www.w3.org/standards/
semanticweb/inference). An inference rule (IR) is a lo-
gical form consisting of a function that takes premises,
analyzes the syntax, and returns a conclusion(s).
To improve data integration and discover new relation-
ships and possible inconsistencies, we have defined seven
inference rules (IRs) in this report. We have first devel-
oped inference rules to capture the physical interaction of
the two entities (agents) in a host-Brucella interaction.
We use the IF p THEN q inference rules to state that,
given the truth of p, allows the truth of q to be inferred.
The IF…THEN rules are used as a knowledge representa-
tion format that can be easily understood and simple to
implement by a computer [22]. Here we formalized the
first inference rule (IR1) to define a host-Brucella inter-
action as following:
(IR1) IF (a agent_in p, ∩ b agent_in p), ∩ p is_a
process, ∩ (a part_of A, ∩ b part_of B) ∩ (A is_a
(host organism ∪ host cell), ∩ B is_a Brucella), THEN
p is_a ‘host-Brucella interaction’
IR1 gives three constrains sufficient to define a direct
host-Brucella interaction: 1) two entities a and b are
agents in a process; 2) these two entities are parts of entity
A and B respectively; 3) A is a host organism or host cell,
and B is a Brucella bacterium. A and B are disjoint with
each other. It is noted that while a direct host-Brucella
interaction involves both host and Brucella molecules, a
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action may be just a typical host or pathogen process
that is triggered by the direct host-Brucella interaction.
In this article, we will provide many examples showing
the pathogen-side or host-side processes following a
direct host-Brucella interaction.
Besides IR1, this article will provide six other IF…THEN
inference rules. The IR2 provides an inference that one
process is preceded by another process after a direct host-
Brucella interaction. IR3-IR7 is about the inference on a
virulence factor. Different from ontology axioms that
usually represent necessary or (necessary and sufficient)
conditions, these IF…THEN inference rules represent
sufficient criteria (IF conditions) for a specific inference
(THEN conclusion).
While ontology axioms behave like inference rules,
the Web Ontology Language (OWL) is unable to express
all relations and inference rules (http://dior.ics.muni.cz/
~makub/owl/#ontology). One common language that can
be used to define inference rules is the Semantic Web Rule
Language (SWRL) developed based on a combination of
the OWL language with the Rule Markup Language
(http://www.w3.org/Submission/SWRL/). While inference
rules do not have to be a part of the ontology, SWRL can
be used to represent the rules in an ontology like IDOBRU
as shown in Additional file 1. These inference rules de-
scribed in an ontology have at least two functions. First,
these rules in combination with a logic reasoner support
ontology consistency check. If an ontology has errors in
conflict with an inference rule, a reasoner like Hermit
(http://hermit-reasoner.com/) will be able to detect the
error. Second, an IF…THEN inference rule can gener-
ate a conclusion on an ontology instance based on spe-
cified conditions.
While inference rules are less frequently used in bio-
medical ontologies, the SPARQL Protocol and RDF Query
Language (SPARQL) has been widely used for querying
ontologies [23] and is familiar to the general readers in
biomedical semantics. In this article, we have also pro-
vided many SPARQL examples to illustrate the usage of
SPARQL in querying information related in host-Bru-
cella interactions.
Ontology modeling of different types of Brucella
Brucella strains can be separated into smooth strains and
rough Brucella strains depending on their lipopolysac-
charide (LPS) compositions. As a major component of the
outer membrane of Brucella, Brucella LPS is composed of
three parts: O polysaccharide (or called O-chain or O-
antigen), core oligosaccharide, and lipid A. The O polysac-
charide, a repetitive glycan polymer attached to the core
oligosaccharide, is the outermost domain of the LPS mol-
ecule. The presence or absence of the LPS O polysacchar-
ide determines whether a Brucella strain has the smoothor rough phenotype, respectively. The presence of full-
length O polysaccharides would render the bacterium
smooth, whereas the absence of O polysaccharides would
make the bacterium rough [24]. Rough Brucella is usually
attenuated, and it does not stimulate the production of
anti-O polysaccharide antibody in an infected host. In con-
trast, most smooth Brucella strains are virulent, and they
have intact O polysaccharides and can stimulate anti-O
polysaccharide antibody in host [25]. Virulent wild type B.
abortus, B. melitensis, B. neotomae, and B. suis are all
smooth strains, and their rough strains (including many
vaccine and vaccine candidate strains) are attenuated.
However, virulent wild type B. canis and B. ovis are
rough. Therefore, the virulent/attenuated and smooth/
rough characteristics of Brucella strains may not match
each other.
In order to define the smooth and rough characteristics
of Brucella, the negative statement of ‘has no Brucella O
polysaccharide’ needs to be addressed. Ceusters et al. has
given a set of ‘lacks’ relations to represent the negative
findings in electronic health records [26]. For example, the
relation lacks_part was defined in terms of the positive re-
lation part_of, holds between a particular p and a universal
u when p has no u as part [26]. However, all relations in
OWL are relations between particulars by default and can-
not represent the relation between a particular and a uni-
versal. It is possible to rely on the punning (an OWL2
feature) that allows OWL developers to use the URI of a
class for an individual (http://www.w3.org/TR/owl2-new-
features/#F12:_Punning). Another shortcoming about the
lacks_part relation in OWL is that the relation in OWL
expression C subClassOf: lacks-part some D implies the
presence of an instance of D where the relation itself
suggests the lack of such an instance [27]. Therefore,
although initially we used the lacks_part relation, we
have recently switched to the use of not has_part as
suggested in the article [27]. Here we adopt their strat-
egy to define the terms ‘smooth Brucella strain’ and
‘rough Brucella strain’ as follows:
Smooth Brucella strain = def a Brucella has_part some
‘smooth Brucella lipopolysaccharide’
Rough Brucella strain = def a Brucella has_part only
‘rough Brucella lipopolysaccharide’
Smooth Brucella lipopolysaccharide = def a ‘Brucella
lipopolysaccharide’ has_part some ‘Brucella O
polysaccharide’
Rough Brucella lipopolysaccharide = def a ‘Brucella
lipopolysaccharide’ not has_part some ‘Brucella O
polysaccharide’
Ontology modeling of host-Brucella interaction subtypes
Brucella bacteria are able to invade and infect both profes-
sional and non-professional phagocytes. The interactions
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of the infection [28]. At least three types of host cells are
recognized: macrophages, dendritic cells, and epithelial cells
(e.g., placental trophoblast cells) [28]. Some cell lines, such
as mouse macrophage cell line J774 [25] and human
epithelial cell line HeLa [29] are important models for
studying host-Brucella interactions. Those cell types
and cell lines have been imported into IDOBRU from
Cell Type Ontology (CL) [14] and Cell Line Ontology
(CLO) [30] respectively by using OntoFox, a web-based
tool for retrieving and extracting ontological terms and
axioms [31].
Given the above three types of host cells and two types
of Brucella strains, we have asserted several subtypes of
host-Brucella interactions using the format of ‘host cell –
Brucella interaction’. Specifically, six subtypes of host-
Brucella interactions were asserted:
1) macrophage – smooth Brucella interaction
2) macrophage – rough Brucella interaction
3) dendritic cell – smooth Brucella interaction
4) dendritic cell – rough Brucella interaction
5) epithelial cell – smooth Brucella interaction
6) epithelial cell – rough Brucella interaction.
Different agents participate in each of the host-Brucella
interactions. For example, the agents in macrophage-Bru-
cella interactions include:
1) ‘Brucella’ agent in ‘macrophage – Brucella
interaction’
2) ‘Brucella’ agent in ‘process of establishing Brucella
infection in macrophage’
3) (‘macrophage’ or ‘macrophage cell line cell’) agent in
‘macrophage – Brucella interaction’
4) (‘macrophage’ or ‘macrophage cell line cell’) agent in
‘macrophage anti-Brucella process’Fig. 1 Ontological representation of various interactions between Brucella5) ‘macrophage-Brucella interaction’ has_part ‘process
of establishing Brucella infection in macrophage’
6) ‘macrophage-Brucella interaction’ has_part
‘macrophage anti-Brucella process’
Figure 1 illustrates the above triples and gives six sub-
types of macrophage-Brucella interactions.
It is noted that the above categorizations do not count
on the interactions between Brucella and host organ
(e.g., spleen) or the whole host at an organism level. As
Brucella is an intracellular bacterium, the macrophage-
Brucella interaction is critical to the outcome of the
host-Brucella interaction [32]. In this article, we will pri-
marily use the macrophage-Brucella interaction processes
as an example for modeling the host-Brucella interactions.
Ontology representation of Brucella invasion, trafficking,
and replication inside host cells
As an intracellular bacterium, the invasion, survival and
replication of Brucella inside host cells are crucial to
Brucella’s lifecycle. The ultimate goal of Brucella is to
propagate in their preferred niche in host cells (particu-
larly the macrophages), where they can reach extensive
replication and subsequently transmitted to new host
cells. The intracellular life of Brucella is a subject of in-
tensive scientific research [28, 32].
Specifically, through different modes of entry into a
macrophage (details given in the following section), a
smooth or rough Brucella cell will enter a Brucella-con-
taining vacuole (BCV) inside a macrophage. The BCVs
containing smooth and rough Brucella cells undergo differ-
ent intracellular trafficking pathways. Smooth BCVs be-
come mature replicative niche, where the bacteria undergo
extensive intracellular replications. In such a replicative
niche, programmed macrophage cell death is prevented,
which is beneficial for the intracellular Brucella. In con-
trast, rough bruellae are fused with lysosome and cannotand host cells
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undergo programmed cell death [25, 33–35]. The process
of rough Brucella interacting with macrophages precedes
the process of programmed macrophage cell death, which
is beneficial for the host.
Brucella: from entry into host cell to replication niche
Smooth and rough Brucella strains utilize different mech-
anisms of entry into host cells. The Brucella LPS O poly-
saccharide is a critical molecule for interaction with lipid
rafts within the plasma membrane of a host cell. The lipid
rafts mediate the internalization of Brucella by phagocytes
and nonprofessional phagocytes in a manner that leads to
the development of the replicative niche [28]. The onto-
logical representation of Brucella entry into macrophages
and other related processes is shown in Fig. 2.
As shown in Fig. 2a, a smooth Brucella LPS (part of Bru-
cella) and a lipid raft from a macrophage (part of macro-
phage) are both agents in the process of the interaction
between smooth LPS and macrophage lipid raft. A lipid
raft is composed of cholesterol (CHEBI_16113), ganglioside
GM1 (CHEBI_61048), and glycosylphosphatidylinositol
(CHEBI_24410). The LPS-lipid raft interaction leads to the
engulfment of smooth Brucella into a macrophage, pre-
ceded with the formation of an early phagosome contain-
ing smooth Brucella. This early phagosome does not fuse
with late endosome or lysosome [28]. The smooth Brucella
containing vacuole (BCV) is acidified and trafficked to anFig. 2 Ontological representation of the entrance into macrophage to replendoplasmic reticulum (ER), where the BCV is fused with
ER membrane. The fusion event leads to the formation of
ER-derived replication niche of smooth Brucella, where the
intracellular replication takes place. It is noted that only a
small percentage of all invading Brucella cells will survive
and achieve their goal of intracellular replications through
the trafficking pathway.
Compared to smooth Brucella, rough Brucella cells have
a different fate (Fig. 2b). Since rough Brucella does not
have LPS O polysaccharide, rough Brucella enters into a
macrophage via direct macrophage engulfment rather than
the lipid raft-dependent engulfment [36]. The early rough
Brucella-containing phagosome is fused with lysosome to
form a rough Brucella-containing phagolysosome, where
the invading bacterium is killed by the macrophage [36].
To formalize the representation of Brucella intracellular
trafficking pathways, five formal relations defined in BFO
were used: participates in, initially participates in, trans-
formation of, begins to exist during, and starts_during.
The terms participates_in and its subclasses initially par-
ticipates in and begins_to_exist_during are three rela-
tions between continuant and process. If a continuant c
begins to exist during a process p, it infers that continu-
ant c does not exist before p starts. If a continuant c ini-
tially participates in a process p, it infers that p cannot
start without the existence of continuant c. Transfor-
mation_of links continuants in a similar fashion as pre-
ceded_by linking processes. Specifically, if continuantication by smooth Brucella (a) and rough Brucella (b)
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exists earlier than c1. The term starts_during represents a
relation between two processes. Taken these five relations
together, the following IR2 is developed to infer the tem-
poral relations between two processes:
(IR2) IF c1 participates in p1, ∩ c initiatively
participates in p2, ∩ c2 begins_to_exist_during p1,
∩ c2 transformation_of c1, THEN p2 starts_during p1
For example, based on the biological fact that an early
smooth Brucella-containing phagosome is transformed
to smooth Brucella-containing vacuole (Fig. 2), the fol-
lowing statements are represented in IDOBRU:
1. ‘acidic phagosome containing smooth Brucella’
participates in ‘smooth Brucella containing
phagosome fusing with ER membrane’
2. ‘ER-derived replication niche of smooth Brucella’
initiatively participates in ‘smooth Brucella
intracellular replication in macrophage’
3. ‘ER-derived replication niche of smooth Brucella’
begins_to_exist_during ‘smooth Brucella containing
phagosome fusing with ER membrane’
4. ‘ER-derived replication niche of smooth Brucella’
transformation_of ‘acidic phagosome containing
smooth Brucella’
Based on IR2, it is inferred that ‘smooth Brucella intra-
cellular replication in macrophage’ starts_during ‘smooth
Brucella containing phagosome fusing with ER membrane’.
The inferred statement is biologically valid [6].
As described in the Methods section, IR2 has been added
to IDOBRU using the SWRL syntax (Additional file 1).
Representing intracellular survival of smooth Brucella inside
macrophages
While a smooth Brucella-containing vacuole is trafficking
within a host cell, the bacteria inside the vacuole encounter
formidable environmental stresses such as the exposures
to reactive oxygen (ROS) and nitrogen species (RNS),
acidic pH, nutritional deprivation, and lytic peptides con-
tained in lysosomes [28]. To withstand these environmen-
tal stresses, Brucella has developed different strategies.
IDOBRU uses several ‘smooth Brucella resistance’ sub-
class terms to represent the resistant processes enabling
smooth Brucella to survive under the stressful environ-
ments within macrophages. Examples of such terms are:
‘smooth Brucella resistance to nutrient deprivation’,
‘smooth Brucella resistance to antimicrobial peptide’,
‘smooth Brucella resistance to nitrosative stress inside
BCV’, ‘smooth Brucella resistance to oxidative stress in-
side BCV’, and ‘smooth Brucella resistance to acidity
stress inside BCV’. The ‘part of ’ relation was used to linkabove processes to ‘process of establishing smooth Bru-
cella survival in macrophage’ in the ontology.
The abilities of smooth Brucella resistance to those
stressful conditions were represented as different types of
‘disposition’. The IDO term ‘protective resistance’ is used
as their direct mother term in virtue of protecting Brucella
from different stresses. Smooth Brucella has the disposi-
tions including ‘nutrient deprivation resistance disposition’,
‘antimicrobial peptide resistance disposition’, ‘oxidative
stress resistance disposition’, ‘nitrosative stress resistance
disposition’, and ‘acidic stress resistance disposition’. These
dispositions are realized in relevant resistance processes
and inhere in a ‘smooth Brucella strain’. For example, the
‘nutrient deprivation resistance disposition’ of smooth Bru-
cella is realized in the process of ‘smooth Brucella resist-
ance to nutrient deprivation’, and ‘smooth Brucella strain’
is the agent participating in the process (Fig. 3).
As the interactions are between host and pathogen,
the response actions of macrophage cells are represented
in IDOBRU using four biological process terms: ‘nitric-
oxide synthase biosynthetic process’ (GO_0051767), ‘re-
active oxygen species metabolic process’ (GO_0072593),
‘acidification of BCV in macrophage’ (IDO_0100758),
and ‘macrophage antimicrobial peptide production’ (IDO_
0100759). All these processes are part of the ‘macrophage
anti-Brucella process’. The unfolds_in relation is used to
capture the fact that those processes take place inside a
macrophage cell (Fig. 3).
Representing Brucella pathogenesis mechanisms
In macrophages, the majority of BCVs fuse with lysosomes
and the bacteria are killed and degraded in the early hours
of internalization [36]. Approximately 10–30 % of internal-
ized Brucella cells are able to survive and undergo the
intracellular trafficking of the host cell [37]. The molecular
mechanisms of Brucella pathogenesis are responsible for
all kinds of interactions with their mammalian hosts. Viru-
lent Brucella employs several strategies and uses many
virulence factors to establish and maintain persistent intra-
cellular residence in host cells. Intracellular Brucella also
alters biological functions of professional phagocytes,
resulting in the losing of their robust antigen-processing
capacity. In order to prevent more hostile extracellular en-
vironment, virulence Brucella is able to prevent the pro-
grammed cell death of infected macrophages [38]. Brucella
pathogenesis relies on the presence of many Brucella viru-
lence factors and their interactions with the host defense
system. Two examples are generated here to illustrate how
IDOBRU represents the interactions between host and
bacterial genes, proteins and pathways.
Representing type IV secretion system
Bacterial type IV secretion systems (T4SS) are often crit-
ical to selective translocation of proteins and DNA–
Fig. 3 Ontological representation of Brucella intracellular survival inside macrophages
Lin et al. Journal of Biomedical Semantics  (2015) 6:37 Page 8 of 18protein complexes [39]. Brucella T4SS, encoded by the
virB operon, is a major virulence factor system [38–41].
Brucella T4SS virB operon includes 12 genes whose ex-
pression is specifically induced by the phagosome acidifi-
cation after Brucella phagocytosis [40]. Brucella T4SS is
required for smooth Brucella trafficking to replication
niches and intracellular survival inside host cells. In
rough strain of Brucella, T4SS expression is important
for Brucella cytotoxicity in macrophages [38].
Figure 4a represents Brucella T4SS and its roles in the
pathogenesis of smooth Brucella. The ‘Brucella virB op-
eron expression’ is preceded by ‘acidification of smooth
Brucella containing phagosome’. The Brucella VirB pro-
teins, encoded by the Brucella virB operon, start to exist
with the expression of the virB operon genes (begin_
to_exist_during). The process of binding a virB promoter
regulates the T4SS virB operon expressions. For example,
VjbR, a LuxR-type quorum-sensing regulator, binds on the
virB promoter, and activates Brucella virB operon expres-
sion [42]. Therefore, VjbR regulates Brucella T4SS directly
and subsequently has an impact on the effectors of T4SS
protein secretions. As shown in Fig. 4a, VjbR is an
agent in the Brucella virB promoter binding process,
which leads to positive regulation of the Brucella virB
operon expression.
Brucella T4SS acts as a translocator of Brucella proteins
or DNA into a macrophage [42]. Entities translocated or
secreted by Brucella T4SS are termed as ‘Brucella T4SS
effectors’, which regulate different processes essential toBrucella intracellular trafficking or replication. A Brucella
T4SS effector is defined as “a molecular entity that bears
the Brucella T4SS effector role” [40]. The ‘Brucella T4SS
effector role’ is a new IDOBRU term that is defined as: “a
role that inheres in a Brucella protein or a DNA upon
which the Brucella T4SS acts, and as a result, the protein
or DNA is secreted out of the bacterium.”
As an example of a Brucella T4SS effector, Brucella pro-
tein RicA (Rab2 interacting conserved protein A), is repre-
sented in IDOBRU to illustrate the Brucella T4SS virulence
mechanism (Fig. 4). Brucella RicA, encoded by a Brucella
gene BMEI0736, binds to human small GTPase protein
Rab2 [43]. RicA is translocated from B. abortus to infected
macrophages. However, this phenomenon does not occur
when a Brucella virB mutant infects the macrophage cell.
Rab2 also coordinates the retrograde Golgi-to-ER transport
[44]. The Rab2 is essential for the formation of the fusion
between BCV and ER, which results in the Brucella replica-
tion niche [45]. As shown in Fig. 4b, Brucella T4SS partici-
pates in the ‘process of translocation of RicA into a
macrophage’ as an agent. Brucella protein RicA bears ‘Bru-
cella T4SS effector role’, and it participates in the processes
of ‘translocation of RicA into macrophage’ and ‘RicA-
Rab2 binding’. The process of ‘RicA binding to Rab2’
leads to the formation of ‘RicA-Rab2 complex’. Rab2
participates in the regulation of Golgi-to-ER transporta-
tion, which regulates the ‘retrograde Golgi-to-ER trans-
port’. Overall, Fig. 4b provides a detailed explanation to
an axiom stated in Fig. 4a: ‘Brucella T4SS effector
Fig. 4 Ontological modeling of Brucella type IV secretion system and its effects. a The general Brucella type IV secretion in Brucella (a) and
example of RicA as T4SS effector (b)
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trafficking’.
Representing Brucella erythritol metabolism
As described earlier, one of the intracellular environmental
stresses that Brucella faces is nutritional deprivation. Bru-
cella uses alternative metabolism pathways to obtain car-
bon, nitrogen, oxygen, phosphorus, sulfur and metals
from its intracellular host [5]. For example, an alternative
pathway for Brucella to acquire carbon is through the
erythritol metabolism [28, 46]. The genome of attenuated
B. abortus vaccine strain S19 includes a 703 nucleotide de-
letion on its ery operon. The deletion affects the gene eryC
coding for an enzyme erythrulose-1-phosphate dehydro-
genase (EryC) and another gene eryD that encodes for
EryD, a regulator of ery operon expression [47]. The dele-
tion is a cause of the attenuation characteristic of strain 19
[48]. The eryCmutant of B. suis also reduces its intracellu-
lar replication in macrophage cells [46].To ontologically represent the virulent characteristic
of EryC, we started by representing the whole process
and its participants at the molecular level and organism
level (Fig. 5):
1) The erythritol metabolism pathway is important for
Brucella intracellular replication. The intracellular
Brucella in a macrophage has the disposition of
uptaking erythritol as the carbon source, which is
realized in the relevant ‘uptaking erythritol process’.
The process of ‘uptaking erythritol as carbon source’
has ‘Brucella erythritol catabolic process’ as its part.
The ‘enzyme substrate role’ of erythritol is realized
in the erythritol catabolic process. The term ‘enzyme
substrate role’ is defined as “A role that inheres in a
protein or a compound upon which enzyme
catalyzes. It is realized in the enzymatic reaction
processes, where the molecules at the beginning of
the process, called substrates, are converted into
Fig. 5 Ontological representation of Brucella erythiritol metabolism and its involvement in Brucella pathogenesis
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product of ‘erythritol catabolic process’ is the
dihydroxyacetone phosphate (DHAP), which is
represented using the relation begins_to_exist_during
as: ‘DHAP begins_to_exist_during erythritol catabolic
process’. The process of ‘uptaking erythritol as carbon
source’ is a partial process of ‘Brucella resistance to
nutrient deprivation’, which accordingly precedes and
is required for the process of ‘Brucella intracellular
replication’. The relation preceded_by is used to
denote the relation between these two processes. Both
‘Brucella response to nutrient deprivation’ and
‘Brucella intracellular replication’ are parts of the
‘host-Brucella interaction’ process (Fig. 5). It is noted
that we did not model the detailed chemical reactions
that are components of the whole erythritol catabolic
process, because it is out of the scope of current
IDOBRU development.
2) Brucella genes eryC and eryD involve in the
erythritol metabolism pathway.
Both eryC and eryD are parts of the Brucella ery
operon. The eryC gene encodes erythrulose-1-
phosphate-dehydrogenase enzyme (EryC), and it
participates in the erythritol catabolic process. The
eryD gene encodes for an EryD protein that regulates
the ery operon expression [47]. The object property
regulates is a relation between processes, and it is
used in GO to represent the fact that a process A has
a direct influence on another process B such that it
controls some aspects of how process B unfolds [49].Therefore, the protein EryD regulates the ery operon
expression (Fig. 5).
3) B. abortus vaccine strain S19 has a 703-nucleotide
deletion which interrupts both the coding regions of
eryC (BAB2_0370) and eryD (BAB2_0369) [48]. The
deletion affects the C terminal part of the Brucella
protein EryC and the N-terminal part of the Brucella
protein EryD [48]. Therefore, S19 lacks the intact
EryD protein and EryC protein as its parts. In the
other example, the eryC mutant of B. suis has no EryC
protein as its part, and it is an agent in the process of
‘reduced intracellular replication in macrophage’ [46].
‘Reduced intracellular replication in macrophage’ is a
compromised intracellular replication process in
macrophage.
Representing host immune responses to Brucella infection
Virulent Brucella is a stealthy bacterium that hijacks many
host immune mechanisms to serve its own survival and
replication inside a host [6]. As introduced above in the
Brucella pathogenesis section, virulent Brucella is able to
replicate inside macrophages which are typically powerful
innate immune cells. Brucella can survive in replicative
phagosomes inside macrophages where nutrients are diffi-
cult to obtain. The Brucella-containing phagosome does
not fuse with bactericidal lysosomes [6]. Furthermore, to
maintain the bacterial natural living niche, virulent Bru-
cella prevents the programmed macrophage cell death.
However, live attenuated Brucella strains, including Bru-
cella cattle vaccine RB51 [50], induce apoptosis or other
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which destroys the Brucella living niche and exposes the
bacteria to the most hostile extracellular environment
[25, 34]. Therefore, the programmed cell death process
benefits the host. Below we ontologically represent and
analyze the process using the example of live attenu-
ated rough B. abortus strain RB51, which is a cattle
brucellosis vaccine licensed and used in the USA and
many other countries [50].
Our previous wet-lab studies have shown that RB51
and many other rough attenuated Brucella strains in-
duce caspase-2-mediated pro-inflammatory cell death
in macrophages through the release of cytochrome c from
mitochondria [34, 35]. RB51 has an insertion within wboA
gene that leads to the deficiency of Brucella LPS O poly-
saccharide and results in its rough phenotype [51]. Figure 6
illustrates ontological representation of RB51-induced
capspase-2-mediated macrophage cell death. In this repre-
sentation, RB51 has no intact wboA gene that encodes for
an enzyme involved in the biosynthesis of Brucella abortus
O-polysaccharide [52]; therefore, RB51 is lack of Brucella
abortus O-polysaccharide. RB51 is an agent in the process
of its infecting a macrophage, which is a part of the
‘macrophage-RB51 interaction’ process. The ‘RB51 infec-
tion of macrophage’ triggers (RO:precedes) three pro-
cesses: ‘activation of caspases-2’, ‘positive regulation of
macrophage programmed cell death’, and ‘positive regula-
tion of macrophage necrotic cell death’. The ‘activation of
caspases-2’ leads to (RO:precedes) ‘positive regulation of
macrophage programmed cell death’. The ‘positive regula-
tion of macrophage cell programmed death’ positively reg-
ulates the ‘apoptotic macrophage cell programmed death’,
which leads to ‘necrotic macrophage cell death’. The ‘nec-
rotic macrophage cell death’ is positively regulated by the
‘positively regulation of macrophage necrotic cell death’.
From a macrophage’s perspective, the macrophage has
two opposite dispositions: 1) the ‘disposition of undergo-
ing programmed cell death’ that is realized by attenuated
RB51 infection of macrophage; and 2) the ‘resistance toFig. 6 Ontological representation of Brucella vaccine strain RB51-induced mprogrammed cell death’ that is realized by ‘virulent Bru-
cella infection of macrophage’.Ontological representation and queries of virulence
factors and associated host-Brucella interactions
Ontology classification of Brucella host-Brucella interactions
involving virulence factors
We previously defined a ‘Brucella virulence factor’ as “viru-
lence factor that bears Brucella virulence factor disposition”
[10]. The ‘Brucella virulence factor disposition’ is defined
as “a disposition borne by a biological macromolecule pro-
duced by Brucella spp. that is the disposition to improve
survival of the pathogen in a host, improve transmission of
the pathogen to a host, or cause pathological processes
in a host”. To further expand the definition, virulence
factors are ontologically classified in this article to be
critical to five pathogen virulence (or microbial patho-
genesis) processes:
1) colonization of a niche in the host (this includes
adhesion to cells);
2) evasion of the host’s immune response;
3) inhibition of the host’s immune response;
4) entry into and exit out of cells (if the pathogen is an
intracellular one);
5) absorption of nutrition from the host.
As shown in the modeling of T4SS and eryC described
above, a Brucella virulence factor is involved in at least
one critical process as part of the host-Brucella inter-
action, or a process precedes the critical process. Although
many Brucella molecules participate in the host-Brucella
interaction processes, not all of them contribute to the
virulence of the Brucella. One method to confirm the sta-
tus of a molecule being a virulence factor is knock-out ex-
perimental evidence, where the pathogen without this
molecule realizes a “reduced” or “abolished” virulence dis-
position during the host-Brucella interaction.acrophage cell death
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mutants
The major category of virulence factors are protein viru-
lence factors that are encoded by virulence genes. Com-
pared to the original IDOBRU that includes 245 Brucella
virulence factors [10], current IDOBRU has been ex-
panded to include 432 experimentally-verified Brucella
virulence factors. All these virulence factors are experi-
mentally verified. The gene mutation followed by experi-
mental examination of the virulence of the gene mutant
inside a host (i.e., the host organism or host cell) is the
major method to detect the status of a pathogen protein
as a virulence factor.
Figure 7 shows how IDOBRU represents a virulence gene
mutant that lacks an intact protein virulence factor. Specif-
ically, a gene mutant is represented in IDOBRU as a mutant
that does not has_part a gene, which also results in the
lack of an intact protein (Fig. 7a). The original IDOBRU
used IDO ontology identifiers with the “IDO_” to represent
Brucella genes and proteins. However, Brucella genes and
proteins may be used in other ontologies such as the Vac-
cine Ontology (VO) [53, 54]. The usage of IDO-specific
identifiers does not support data integration and resource
interoperability. As detailed in the Methods section and
shown in Fig. 7, in the new version of IDOBRU, we have
imported the Ontology of Genes and Genomes (OGG) IDs
(Fig. 7b) and Protein Ontology (PRO) IDs (Fig. 7c) to repre-
sent the genes and proteins of Brucella virulence factors.
OGG is a relatively new ontology that represents specific
genes in different species [19]. PRO is an ontology of pro-
tein entities [20]. To link the gene and protein entities, weFig. 7 IDOBRU representation of a Brucella virulence gene mutant. The ex
mutant has a mutation of strain 2038 sodC gene (b), which encodes a pr
relation ‘has_gene_template’ is used to link the protein to the gene. Thehave adopted the PRO relation ‘has_gene_template’ to rep-
resent a protein encoded by a gene (Fig. 7c), and the rela-
tion ‘encodes’ to represent a gene encoding a protein.
Description rules to define virulence factors
To establish logical reasoning for a virulence factor, we de-
veloped five description rules as defined below. In the for-
mulation of these rules, o denotes an organism O, g and g’
denote genetic materials, e denotes a molecular entity, p
denotes a process, i denotes a host-pathogen interaction
process, and mo denotes a mutant of O.
(IR3) IF o has_part g, ∩ g encodes e, THEN o
has_part e
IR3 means that if an organism has part of a gene that
encodes for a molecular entity (i.e., gene product such
as protein), then this organism has part of the molecu-
lar entity.
(IR4) IF mo has_part g’, ∩ g’ derives_from g, ∩ (g’ not
has_part part of g) ∩ genome of o has_part g, THEN
genome of mo not has_part g
IR4 means that if a mutant of an organism has an arti-
ficially altered gene g’ that is derived from g, either by an
insertion or partial deletion, then the genome of the mu-
tant has no intact g as its part. When the g is fully de-
leted (i.e., g gene knock-out) from mutant mo, the above
rule will not apply. In this case, we simply assert that
genome of mo not has_part g (see below).ample shown here is B. abortus strain 2308 sodC mutant (a). This
otein called Copper/Zinc Superoxide Dismutase (SOD) (c). The
screenshots came from the IDOBRU page in Ontobee [61]
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has_part g
If the genome of mutant has no intact gene g as its
part, the mutant has no g as its part.
(IR6) IF genome of mo not has_part g, ∩ g encodes e,
THEN mo not has_part e
IR6 means that if the mutant has no intact gene g as
its part, and the gene g encodes the molecular entity e in
the non-mutated organism, then the mutant has no in-
tact e as its part.
IR7 was given as a final inference rule for inferring a
virulence factor:
(IR7) IF (mo has disposition at some time
attenuated disposition ∩ attenuated disposition
realized in i) ∩ mo not has_part e, ∩ (mo
agent_in_compromised_process p ∩ p is_a pathogen
virulence process), THEN e is_a virulence factor.
For example, as shown in Fig. 5, (B. abortus eryC mu-
tant not has_part EryC) AND (B. abortus eryC mutant
agent_in_compromised_process Brucella intracellular
replication in macrophage) AND (Brucella intracellular
replication in macrophage is_a pathogen virulence
process) means that EryC is_a Brucella virulence factor.
According to IR6, if a gene g encoding a protein e is mu-
tated from a mutant, the mutant does not have the in-
tact protein e any more. Since eryC is mutated from the
eryC mutant, we can infer that the eryC mutant does
not have EryC.
We can therefore identify the biological process import-
ant to the pathogen virulence during the host-Brucella
interaction. Using the same Fig. 5 example, (EryC partici-
pate_in Brucella erythritol catabolic process) AND (EryC
mutant of B. abortus agent_in_compromised_process
intracellular replication in macrophage), which means
that the Brucella erythritol catabolic process is crucial to
the intracellular replication in macrophage.
With the support of the above representations defined
by IR3-7, we have annotated 269 virulence factors asso-
ciated with various macrophage-Brucella interactions.
IR7 is included in IDOBRU (Additional file 1: Figure S1).
SPARQL queries of IDOBRU for virulence factors critical for
host-Brucella interactions
In this study, several SPARQL scripts were generated to
query the information related to host-Brucella interac-
tions. The details are provided below:
First, a simple SPARQL script was generated to query the
number of protein virulence factors collected in IDOBRU
(Additional file 2). Each virulence factor protein is ‘bearerof at some time’ (BFO_0000053) some ‘Brucella virulence
factor disposition’ (IDO_0100116). The query identified
432 protein virulence factors.
The second SPARQL query identifies the processes in
which Brucella virulence factors participate (Fig. 8). Specif-
ically, the script queries what compromised processes Bru-
cella virulence factor mutants get involved in. The relation
‘agent_in_compromised_process’ as described earlier is
used here. In total, 11 biological processes, for example,
‘Brucella entry into macrophage’ (IDO_0100610) and
‘Brucella intracellular trafficking’ (IDO_0100983), were
identified (Fig. 8). These processes are critical to Bru-
cella pathogenesis inside host cells.
Third, those Brucella mutants that are attenuated in-
side macrophages during various macrophage-Brucella
interactions were identified using SPARQL (Additional
file 3). Each of these mutants is associated with a par-
ticular gene (represented in OGG) and a corresponding
protein (represented in PRO) (Fig. 7). Therefore, the
queries also provide us a way to extract those virulence
genes and virulence factors important for macrophage-
Brucella interactions. In total, 269 gene mutants that are
associated with 269 genes and protein virulence factors
were found. The list of all these gene mutants is also
provided in Additional file 3.
Fourth, the Brucella protein virulence factors import-
ant for Brucella intracellular replication inside macro-
phages were detected using two SPARQL queries
(Additional file 4). A query identified 81 such virulence
factors, and the other query provided the detailed list
of these factors (Additional file 4).
It is noted that the inference rules IR3-7 provide the
logic clues on the second and third sets of queries. Spe-
cifically, to search Brucella virulence factors important
for intracellular replication in macrophages, first we re-
trieved all possible gene mutants. Each protein encoded
by a gene mutated in a mutant is an agent involved in the
compromised process of ‘macrophage-Brucella interaction’
(IDO_0100832) (Additional file 3: Figure S3) or ‘Brucella
intracellular replication in macrophage’ (IDO_0100612)
(Additional file 4: Figure S4). The relation ‘agent_in_com-
promised_process’ as described earlier is used here. Due to
the mutation event, the intact Brucella protein (virulence
factor) does not exist in the mutant organism (IR4 and
IR6). Therefore, we are able to retrieve all the correspond-
ing virulence factor proteins using the not has_part rela-
tion (Additional file 4: Figure S4).
Discussion
Compared to the original IDOBRU paper published in
2011 [10], current article included several novel contri-
butions. First, while the original paper only includes one
section with one figure in the topic of the host-Brucella
interaction (i.e., virulence factor and pathogenesis),
Fig. 8 SPARQL query of biological processes involving Brucella virulence factors. This script queries the compromised Brucella processes in which
Brucella virulence gene mutants participate. The query was performed using the Ontobee SPARQL web-interface (http://www.ontobee.org/sparql).
The IDO_0101168 in the script is ‘agent_in_compromised_process’
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different aspects of the host-Brucella interactions. Specific-
ally, this article first ontologically differentiates smooth and
rough Brucella phenotypes and how each phenotype is re-
lated to Brucella virulence. Six host-Brucella interaction
subtypes are categorized, and the agents participating in
any of the subtypes (i.e., macrophage-Brucella interaction)
are defined. IDOBRU is also used to represent detailed
processes of Brucella invasion, trafficking, and replication
inside host cells. Examples described in this article include
two major Brucella pathogenesis mechanisms: the Type IV
secretion system (T4SS) and the erythritol metabolism. In
terms of host immune response against Brucella infection,
the inhibition or promotion of host programmed cell death
is specifically modeled using IDOBRU. Regarding the viru-
lence factors, this article for the first time ontologically
classifies five different types of host-pathogen interaction
processes where virulence factors may play a critical role.
Approximately 200 more virulence factors have been in-
cluded in current IDOBRU since the original IDROBRU
publication. Second, seven specific inference rules are gen-
erated and described in this paper for reasoning related to
host-Brucella interactions and Brucella virulence factors.
The layout and implementation of these inference rules
provide more power in using IDOBRU for computer-
assisted reasoning. Third, this article introduces an updated
style of representing Brucella genes and proteins. Instead
of using IDO IDs to represent genes and proteins, theupdated IDOBRU imports OGG and PRO IDs for more
authentic representations of Brucella genes and proteins.
Such gene/protein representations support ontology reuse
and interoperability. Fourth, this article provides many
SPARQL scripts that demonstrate the applications of IDO-
BRU. Furthermore, many more ontology terms have been
added to IDOBRU. Compared to the original IDOBRU
version published in 2011 that includes 1503 terms,
current version 1.2.79 includes 3488 terms. We have
more than doubled the numbers of the terms in the
IDOBRU ontology, clearly showing our progress in the
IDOBRU development.
Other literature reports exist for ontological modelling
of host-pathogen interactions. The Plant-Associated Mi-
crobe Gene Ontology (PAMGO) Consortium uses GO for
modeling host-pathogen interactions based on the investi-
gation of plant-associated symbionts [55]. Their efforts
yielded a group of GO biological process terms that cap-
ture the processes occurring between hosts and symbionts
(from mutualists to pathogens). PAMGO is focused on
representing processes. Representation of host partici-
pants (e.g., organelle like ER, and cell membrane) and
pathogen details (e.g., LPS of Brucella, Brucella proteins)
was not covered. IDO-core provides many top level terms
in the area of host-pathogen interactions, such as estab-
lishment of localization in host (IDO_0000625). As an ex-
tension ontology of IDO-core, the Malaria Ontology team
developed several terms related to malaria-host interact
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ness to host cue’ [56]. Another ontology named Host
Pathogen Interaction Ontology (HPIO) found on NCBO
BioPortal is current under development, which aims to
describe the host-pathogen interactions between Salmon-
ella bacteria and swine, also as an extension of IDO-core.
However, HPIO does not represent the interactions be-
tween host and pathogens extensively. None of the above
efforts covers the participants of the interaction processes
and relations between those processes. In contrast, IDO-
BRU represents various participants in the interaction
processes between Brucella and its hosts with details at
the organism, cell, and molecular levels. IDOBRU is used
as a framework to model different proteins, complexes
and interaction processes such as how virulence factors
play a role in the Brucella-host interactions and how the
interactions happened as a series of sequential events. To
support data standardization and exchange, formal rela-
tions are applied in the IDOBRU modeling. To the best of
our knowledge, our IDOBRU modeling and representa-
tion of various areas of host-Brucella interactions repre-
sent the first comprehensive host-pathogen interaction
ontological analysis.
The host-Brucella interaction is modeled in IDOBRU as
a process with many specific interaction subclasses. The
interactions between Brucella and hosts are Brucella-spe-
cific and host (e.g., host organism or cell) - specific. For
example, the pathway of Brucella entry into macrophage
differs from the bacterial entry into epithelial cell, and the
immune response and intracellular trafficking induced by
Brucella infection differ among professional and non-
professional phagocytes [57]. Therefore, it is important to
classify different subtypes of host-Brucella interactions by
host cells. The macrophages are emphasized in this study
since macrophage is likely the most critical host cell type
in terms of host-Brucella interactions [32]. More onto-
logical representations with other host cells are needed.
Similarly, we will need to classify the subtypes based on
host organism or host organs as well, since the infection
of any Brucella strain has its host preference. These as-
pects are critical to the development of host-specific Bru-
cella vaccines.
Compared to well-studied model organisms such as E.
coli, Brucella is less studied, and the coverage of Brucella
research is often unbalanced and limited. For example,
middle products and enzymes involved in the erythritol
catabolism pathway in Brucella are not available in PRO
or ChEBI. We communicated the PRO and ChEBI groups
and submitted related middle product terms to ChEBI
and enzyme terms to PR. For example, over 1000 Brucella
strain specific proteins were submitted to PR. Although
the enzyme databases and knowledge bases are well devel-
oped and contain authentic comprehensive information,
the erythritol catabolic pathway is not included in well-known enzyme databases such as BRENDA (http://
www.brenda-enzymes.org/). GO has very few gene prod-
ucts from Brucella annotated with experimental evidence
codes (http://www.geneontology.org/GO.evidence.shtml).
The inference rules (IR3-IR7) generated in this study pro-
vide a framework on inferring virulence factors. These rules
can be used for validating the ontology and populating the
ontology. These inference rules can also be generalized to
other pathogen. The inference rules represent knowledge
and provide a format for computer-understandable auto-
mated reasoning. These rules offer explicit and transparent
assumptions for representing virulence factors in the case
of the host-Brucella interaction. Based on the inference
rules and available data, a computer will be able to assess if
a material entity is a specific virulence factor. Since the
mechanisms of virulence are different from species to spe-
cies, more inference rules may be developed with different
types of pathogens (e.g., HIV virus).
SPARQL provides a powerful method for querying and
analyzing the data in an ontology [58]. For example, our
queries identified 269 protein virulence factors related to
macrophage-Brucella interactions; and among these pro-
teins, 81 are important for intracellular replication within
macrophage from the knowledge stored in current IDO-
BRU. Note that virB1, virB5, virB8, virB9 and virB10 are
in the above list, which validates the modeling of T4SS
mechanism in this paper. In addition, we have identified
11 biological processes important for Brucella virulence
(Fig. 8). These simple but powerful SPARQL queries dem-
onstrate the applications of IDOBRU and IDOBRU-based
SPARQL technology.
One important contribution of this paper is its first re-
port in co-representing genes and proteins using the
Ontology of Genes and Genomes (OGG) [19] and the
Protein Ontology (PRO) [20]. The majority of Brucella
virulence factors are proteins, which are encoded by spe-
cific genes in different Brucella strains. The practice of
using IDOBRU IDs in our original IDOBRU version was
not ideal since it does not support ontology reuse and in-
tegration. To address this issue, the new version of IDO-
BRU uses the gene and protein IDs from the OGG and
PRO, two ontologies in the OBO ontology library. The
OGG ontology was recently developed to represent genes
from specific organisms by reusing existing resources, pri-
marily the NCBI Gene resource [59]. Due to the large
numbers of genes available in different organisms, OGG
includes different subsets, each of which represents genes
from one or a few organisms. Using the OGG develop-
ment strategy, we first generated the OGG Brucella subset
that covers all genes of three major Brucella strains. All
virulence factor genes covered in IDOBRU are from these
three Brucella strains. The availability of the OGG Brucella
subset allows us to retrieve and reuse the OGG terms to
represent Brucella genes in IDOBRU. Similarly, specific
Lin et al. Journal of Biomedical Semantics  (2015) 6:37 Page 16 of 18Brucella proteins were generated in PRO and reused in
IDOBRU. Furthermore, using two object properties (i.e.,
‘has_gene_template’ and ‘encodes’), we were able to repre-
sent the relations between genes and proteins. Since genes
and proteins are two fundamental entities in biology, this
study provide a demonstration on how these can be onto-
logically represented and interlinked.
Conclusions
In this paper, we ontologically represent various Brucella-
host interactions primarily using the Brucella-macrophage
interaction as a use case. A formal definition of the Bru-
cella-host interaction was given in OWL format. After the
definitions on smooth and rough Brucella are given, six
subtypes of Brucella-host interactions are classified ac-
cording to the Brucella phenotypes and host cell types.
IDOBRU is further used as a platform to represent inter-
active processes including Brucella invasion, intracellular
trafficking and intracellular replication at an organism
level. By representing the Brucella pathogenesis mecha-
nisms using Brucella T4SS and EryC examples, we dem-
onstrate how to ontologically link biological processes
from the organism level down to the molecular level. De-
scription logical inference rules have also been defined to
infer: 1) the interaction process between two species (i.e.,
a host and a pathogen); 2) the temporal relations of bio-
logical processes; 3) relations between gene, protein, gen-
ome, and gene mutant; and 4) a virulence factor. For this
study, many new terms have been added into IDOBRU.
Using SPARQL queries generated based on inference
rules, out of the 269 virulence factors related to macro-
phage-Brucella interactions, 81 virulence factors were
found to be important for Brucella intracellular replication
inside macrophage. Eleven biological processes were also
found important for Brucella virulence.
Methods
Ontology editing
The format of W3C standard Web Ontology Language
(OWL2) (http://www.w3.org/TR/owl-guide/) was applied
for IDOBRU development. The Protégé OWL ontology
editor (http://protege.stanford.edu/) (versions 4.3 and 5.0
beta) was used to edit IDOBRU.
Existing ontology term import
The ontology development uses a hybrid bottom-up and
top-down method as described in our original IDOBRU
article [10]. For this host-Brucella interaction study, many
external ontology terms from existing ontologies, includ-
ing Cell Type Ontology (CL) [14], Chemical Entities of
Biological Interest (ChEBI) [15], Gene Ontology (GO)
[16], Protein Ontology (PRO) [20], were imported to IDO-
BRU using OntoFox (http://ontofox.hegroup.org/) [31].IDOBRU access and visualization
The latest version of IDOBRU is always available at Source-
forge website: (http://svn.code.sf.net/p/idobru/code/trunk/
src/ontology/brucellosis.owl). Not that this is an unmerged
OWL file, and it imports many other OWL files in the
same folder. Therefore, it would be best to get all the re-
lated ontology files via SVN. IDOBRU has also been depos-
ited in the NCBO BioPortal (http://bioportal.bioontology.
org/ontologies/IDOBRU) and the Ontobee linked ontology
browser system (http://www.ontobee.org/browser/index.
php?o=IDOBRU). Both NCBO BioPortal and Ontobee pro-
vide interactive search and visualization features for IDO-
BRU exploration and analysis.OGG and PRO representation of Brucella virulence factors
The Brucella subset of the Ontology of Genes and Ge-
nomes (OGG) was generated using a method described in
the OGG paper [19]. Specifically, a NCBITaxon subset
was generated to include three Brucella strains using
OntoFox [31]. These strains are B. abortus strain 2308, B.
suis strain 1330, and B. melitensis strain 16 M. All anno-
tated Brucella genes in IDOBRU come from these three
strains. Most of the information of all added Brucella
genes encoding protein virulence factors was obtained
from the manually annotated Victors database (http://
www.phidias.us/victors) in the PHDIAS resource [60].
The OGG Brucella subset was submitted to the He group
RDF triple store [61]. OntoFox was then used to retrieve
the Brucella genes covered in IDOBRU.
The corresponding proteins encoded by these Brucella
genes are represented by Protein Ontology (PRO) [20].
OntoFox was used to extract the information of these
proteins from PRO. The resulting PRO subset was then
imported to IDOBRU.Queries of IDOBRU
SPARQL scripts were developed to query IDOBRU using
the IDOBRU SPARQL query web page (http://www.
phidias.us/bbp/idobru/sparql/index.php) located in the
Brucella Bioinformatics Portal (BBP; http://www.phidias.
us/bbp) [60, 62].Implementation of inference rules
The reasoner HermiT 1.3.8 (http://hermit-reasoner.com/)
as a plugin in the Protégé OWL editor (http://protege.
stanford.edu/) was used to implement the inference
rules defined in this paper. The rule view editor in the
Protégé OWL editor was used to edit the rules. The
ontology rule view in Protégé is accessible from the
Protégé menu Window→ Views→Ontology views→
Rules. The saved IDOBRU OWL file contains the rules
in the format of OWL with SWRL codes.
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